Rigel Pharmaceuticals
RIGL
#6656
Rank
ยฃ0.57 B
Marketcap
ยฃ30.65
Share price
-2.67%
Change (1 day)
-13.18%
Change (1 year)

Earnings for Rigel Pharmaceuticals (RIGL)

Earnings in 2026 (TTM): ยฃ68.35 Million

According to Rigel Pharmaceuticals's latest financial reports the company's current earnings are ยฃ0.27 Billion. In 2025 the company made an earning of ยฃ98.72 Million, an increase over its 2024 earnings that were of ยฃ20.09 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Rigel Pharmaceuticals from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) ยฃ68.35 M-30.76%
2025 ยฃ98.72 M391.35%
2024 ยฃ20.09 M-244.27%
2023 -ยฃ13.93 Million-66.79%
2022 -ยฃ41.95 Million340.73%
2021 -ยฃ9.52 Million-56.15%
2020 -ยฃ21.71 Million-57.34%
2019 -ยฃ50.88 Million-7.66%
2018 -ยฃ55.1 Million-9.47%
2017 -ยฃ60.87 Million24.46%
2016 -ยฃ48.91 Million23.63%
2015 -ยฃ39.56 Million-43.29%
2014 -ยฃ69.76 Million2.5%
2013 -ยฃ68.06 Million
2010 ยฃ28.93 M-133.97%
2009 -ยฃ85.19 Million-18.49%
2008 -ยฃ0.11 Billion71.91%
2007 -ยฃ60.8 Million84.74%
2006 -ยฃ32.91 Million-10.17%
2005 -ยฃ36.64 Million-15.73%
2004 -ยฃ43.48 Million39.29%
2003 -ยฃ31.21 Million10.3%
2002 -ยฃ28.3 Million48.3%
2001 -ยฃ19.09 Million-2.13%
2000 -ยฃ19.5 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
ยฃ8.44 B 11,994.42%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
ยฃ11.53 B 16,412.19%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sangamo Therapeutics
SGMO
-ยฃ84.34 Million-220.73%๐Ÿ‡บ๐Ÿ‡ธ USA
ChemoCentryx
CCXI.defunct
-ยฃ99.84 Million-242.92%๐Ÿ‡บ๐Ÿ‡ธ USA